SCHEMBL6947679

SCHEMBL6947679

C=CCn1c(NC=O)nc(N2CCc3ccccc3CC2)c(C#N)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.39
CASP1 P29466 3/20 0.39
CASP7 P55210 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
ALDH1A1 P00352 11/20 0.37
KDM4E B2RXH2 10/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
HSD17B10 Q99714 4/20 0.37
HTT P42858 5/20 0.37
HIF1A Q16665 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950841 0.89 ALDH1A1 (0.45) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6950993 0.88 ALDH1A1 (0.40) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6950036 0.88 ALDH1A1 (0.40) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6952171 0.87 GRM2 (0.39) MAPTCASP1CASP7ALDH1A1KDM4E
SCHEMBL6954163 0.86 MAPT (0.39) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6951049 0.85 MAPT (0.41) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6949369 0.84 MEN1 (0.43) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6949202 0.82 ALDH1A1 (0.37) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6948222 0.82 MAPT (0.39) MAPTCASP1CASP7CYP1A2CYP3A4
SCHEMBL6951063 0.81 PDE4A (0.43) MAPTCASP1CASP7CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed